DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

Technological advancements in the spinal cord stimulators to favor growth

The key players are adopting strategies such as mergers and acquisitions, partnerships, and regional expansion to stand out as strong competitors in the market.

North America is dominating the global spinal cord stimulation market in 2020 and is estimated to hold significant market size over the forecast period (2021-2028)

In the EU-27, overall waste generation increased by 5% (114 million tons) between 2010 and 2018.

Europe electroporation instruments & consumables market is estimated to grow at a CAGR of 6.8% during the forecast period

The sleep apnea devices market is fragmented in nature with the presence of various international as well as regional players.

The Asia Pacific sleep apnea devices market is anticipated to witness a significant growth rate during the forecast period.

Increasing the awareness and improving the diagnosis and treatment of sleep disorders necessitates a multipronged effort that includes three key components: public education, training for health professionals, and surveillance and monitoring.

Some of the key players which are contributing to the growth of the market include Merck KGaA, Eppendorf AG, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, MaxCyte Inc., Lonza Group, among others.

The electroporation technique is widely preferred to enhance nucleic acid uptake with the DNA to generate an immune response against an antigen when the vaccine is delivered through the skin.

The North America segment is estimated to account for a share of approximately 34.0% of the N95 Masks market by 2020 and is anticipated to grow to 35.2% by 2028.

The major drivers fueling the growth of the market are an increase in the coronavirus cases. As of March 2021, almost 132 million were affected by the virus, resulting in 2.87 fatalities globally. 

Asia Pacific ophthalmology amniotic membrane market valued USD 106.7 million in 2020

Each aspect of healthcare provision including cancer care has been disrupted by the COVID-19 pandemic. 

North America Blood Cancer Drugs market is estimated to grow at a CAGR of 7.3% during the forecast period (2021-2028)

According to Bristol-Myers Squibb Company report, over 1.85 million new blood cancer cases are expected to be diagnosed across the globe in 2040, out of which 918,872 cases are from lymphoma, 656,345 from leukaemia, and 275,047 cases myeloma.

The World Health Organization (WHO) estimates that, in Europe, 20% of the burden of disease transmitted through food is caused by T. gondii infection.

The World Health Organization (WHO) estimates that, in Europe, 20% of the burden of disease transmitted through food is caused by T. gondii infection. Seroconversion rates vary greatly around Europe, ranging from 7% to 10% in Norway and the United Kingdom to 44% and 50% in France and Germany respectively.

Asia Pacific is expected to be the fastest-growing market over the forecast period.

The North America hematology analyzers and reagents market was valued USD 2,670.0 million in 2020

The global bio-pharmaceutical portfolio of today reflects increased therapeutic competition, a greater prevalence of large molecule drugs, expansion in the number of personalized or targeted products, and a rise of treatments for many orphan diseases. 

According to the Commonwealth of Australia 2018, more than 330,000 affected infants are born each year (83% sickle cell disorders and 17% thalassemia), around 7% of pregnant women are carriers of hemoglobin disorders, and over 1% of couples are at risk level.

The Middle East & Africa biopharmaceuticals market was valued at USD 21,786.3 million in 2020

Increasing Demand For The Technologically Advanced Treatment Procedure

According to a research article by Claudia Benedetti et al., published in Frontiers in Medicine Journal 2020, the study results indicate that patients with kidney disease could represent a risk factor in elderly patients, for a more severe disease course. COVID-19 infects the kidneys and may induce acute kidney injury. 

Recombinant adeno-associated virus (rAAV) is obtained from a small human parvovirus with an exceptional safety profile

The rising frequency of unruptured intracranial aneurysm (UlAs) detection is one of the major factors driving the aneurysm coiling and embolization devices market growth. 

Opioid consumption in Spain has increased by 84% from 2008 to 2015, moving from 7.25 Defined Daily Doses/1000 inhabitants/day in 2008 to 13.31

The South  America segment is estimated to account for a share of approximately 9.16% of the global urinary catheters market by 2018 and is anticipated to grow to 8.42% by 2027.

> Europe Anaphylaxis Treatment Market Expected to reach at a high CAGR of 6.6% by 2027: DataM Intelligence

> COVID-19 is causing a dramatic mismatch of supply and demand that manufacturers are struggling to forecast

> Global Bronchodilators Market Expected to reach at a high CAGR of 6.2% by 2027: DataM Intelligence

The COVID-19 outbreak will impact the bronchodilators market in the initial phase of the forecast period. Due to nationwide lockdowns, denied asthma, and COPD treatment due to COVID patents are a priority for hospitals and shortage of bronchodilators, the bronchodilators market is expected to register a certain decline during the forecast period.

The modernization of public healthcare and up-gradation of the equipment will drive the growth in dialysis treatments in coming years.

As per the official government guidelines, India is making preparations against the COVID-19 outbreak, and avoiding specific crisis actions or not understating its importance will have extremely severe implications. All the neighboring countries of India have reported positive COVID-19 cases

The North America Radiopharmaceutical Market is valued at US$  2,810.3 Million in 2019

DMI segments the Global Radiopharmaceutical Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa

The North America digital x-ray market is valued at USD 3,043.4 Mn in 2019 and is estimated to grow at a CAGR of 7.2 % over the forecast period to reach USD XXMn by 2027.

According to the World Health Organization, as of 8 November 2020, there have been 49,578,590 confirmed cases of COVID-19, including 1,245,717 deaths globally.

The North America market is estimated to grow at a CAGR of 6.9% during the forecast period (2020-2027)  to reach a market value of USD YY million by 2027.

The rising demand for blood plasma in biopharmaceutical companies is also one of the major factors leading to growth of the apheresis market.

Growing Incidence Of Chronic Diseases & Rapidly Growing Number Of Surgical Procedures Are Key factors for market growth during the forecast period

The global enzyme-linked immunosorbent assay (ELISA) market is primarily driven by the increasing incidence of chronic diseases such as infectious diseases, vector-borne diseases, cancer, among others.

The Europe targeted temperature management market is valued at USD 643.2 Mn in 2019 and is estimated to grow at a CAGR of 6.6% over the forecast period to reach a USD YY Mn by 2027.

The North America targeted temperature management market is valued at USD 847.0 Mn in 2019 and is estimated to grow at a CAGR of 7.3% over the forecast period to reach a USD YY Mn by 2027.

Rising demand for leak detection in water and wastewater management applications 

On the basis of source, the market is segmented into synthetic and natural. Synthetic is further segmented into Polymers, Oxidized Regenerated Cellulose (ORC) and Ethylene Diamine Tetraacetic Acid (EDTA). Natural segment is further sub segmented into porcine, bovine and avian.

Growing Prevalence of Diseases and Conditions Affecting Wound Healing Capabilities

The North America glioblastoma multiforme market is valued at USD 409.3 Mn in 2019 and is estimated to grow at a CAGR of 8.4% over the forecast period to reach USD YY Mn by 2027.

Drivers influencing the market growth of Glioblastoma Multiforme Market

The South America medical oxygen concentrators market is valued at US$ 275.18 Mn in 2018 and is expected to grow at a CAGR of 7.2% over the forecast period to reach a US$ YY Mn by 202

Growing Prevalence Of Diseases And Conditions Affecting Wound Healing Capabilities

Growing development of optical communication and increasing wireless devices

According to the World Health Organization (WHO), in Japan chronic diseases accounted for 80% of deaths in 2002. Chronic diseases are increasing three fold in the country due to a large number of smoking population, a prominent section of the population being old and rising population in the country.

The global market for bioresorbable implants is primarily driven by the growing cases of chronic diseases and the increasing geriatric population worldwide.

Single-use bioprocessing in biopharmaceutical manufacturers is expected to witness high growth in the future due to its various advantages over conventional fixed bioprocessing methods.

High Focus on Improved Drug Screening and growing applications of organ-on-chip

Increasing Prevalence of Cancer and Cardiovascular Diseases

Increasing demand for transportation of pharmaceutical medicines, vaccines, drugs and clinical trial distribution products, tissue, donor organs, blood transfers around the globe. 

Increasing Initiatives Taken by Governments and Animal Welfare Associations

DMI segments the 3D Printed Drugs Market By Drug (Spritam, Others), By Technology (Inkjet printing, Fused deposition modelling, Stereolithography, Others), By End-User (Hospitals, Clinics, Research Laboratories, Others)

Rising awareness of brain health supplement’s benefits 

DMI segments the Global Toxoplasmosis Testing Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

 Increasing Occurrence of Serious Injuries, Orthopedic Diseases and Cancer

DMI segments the Global Cold Plasma Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

Global Viral Vector and Plasmid DNA Manufacturing Market is segmented by product type Plasmid DNA, Viral Vector, Non-Viral Vector and Others

Frontotemporal Disorders Treatment Market Segmented by drug class are cognitive enhancers, Antidepressants, Antipsychotics, CNS stimulants and Others.

DMI segments the Global Pharmaceutical Mass Flow Controller Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa

DMI segments the Global Medical Imaging Equipment Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa

DMI segments the Local Anesthesia Drugs Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the North America 3D Printed Drugs Market By Drug (Spritam, Others), By Technology (Inkjet printing, Fused deposition modelling, Stereolithography, Others), By End-User (Hospitals, Clinics, Research Laboratories, Others)

DMI segments the Global Dental Consumables Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Hemodialysis Equipment Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Saudi Arabia Laboratories Market by Product Type (Analytical Equipment, General Equipment, Specialty Equipment, Support Equipment, Others), by End User (Life Science Research, Clinical Research, Medical Diagnostics, Pharmaceutical Research and Development, Others)

DMI segments the Global Diabetic Neuropathy Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments The Global Household Insecticides Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments The China Companion Animal Health Market by Animals like Dogs, Cats, Horses, Others

DMI segments the Global Animal Anti-rabies Vaccine Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Arthroscopy Devices Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Bone Grafts And Substitutes Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Medical Device Packaging Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Urinary Catheters Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Cancer Molecular Diagnostics Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Skin Substitutes Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments The Medical Refrigerators Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Inhalation Therapy Nebulizer Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Gout Therapeutics Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Anaphylaxis Treatment Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Veterinary Pain Management Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Uterine Fibroids Treatment Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Slide Stainer Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Pregnancy Testing Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Prostate Cancer Imaging Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Medical Second Opinion Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Facial Aesthetics Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Mechanical Ventilator Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Dermal Fillers Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Hemophilia Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Preclinical in-vivo Imaging Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Electronic Stethoscope Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Colposcopes Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Cancer Monoclonal Antibodies Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Anticoccidial Drugs Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Wound Care Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Diabetic Foot Ulcer Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Interspinous Spacers Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the South America Durable Medical Equipment Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Vocal Fold Augmentation Products Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Active Pharmaceutical Ingredients Market into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the US MRI Market into – Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Wound Debridement Products Market into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Voice Restoration Devices Market into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Dilated Cardiomyopathy (DCM) Market into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Digital Signage Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Global Cholangitis Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.

DMI segments the Artificial Heart-Lung Machine Market by geography into – North America, South America, Europe, Asia-Pacific (APAC), and Middle East and Africa.